What Have Observational Studies Taught Us About Brain Health? An Exploration of Select Cardiovascular Risks and Cognitive Function

2024-9-1

The effects of a six-month exercise intervention on white matter microstructure in older adults at risk for diabetes

2024-9-1

Editorial. CCCB: The Journal at Age 5

2024-9-1

In memoriam, Timo Juha Erkinjuntti, MD PhD, Professor in Neurology, University of Helsinki, Finland

2024-8-1

VasCog 2023: 20 years of research on vascular cognitive and behavioural disorders

2024-5-1

Cortical microstructural involvement in cerebral small vessel disease

2024-3-1

The Luigi Sacco Hospital VAS-COG stroke care pathway: a five-year experience

2024-2-1

Maintenance of Brain Health: The Role of Social Determinants of Health and Other Non-Traditional Cardiovascular Risks

2024-2-1

Validation of the Brain Health Index in the European Prevention of Alzheimer's Dementia cohort

2024-2-1

DEveloping BBB-ASL as non-Invasive Early biomarker of Alzheimer's Disease (DEBBIE-AD): Study design

2024-1-1

TRAJECTORIES OF COGNITIVE CHANGE FOLLOWING STROKE: A STEPWISE DECLINE TOWARDS DEMENTIA

2024-1-1

Vascular phenotypes in memory clinic patients; preliminary results of the VARIATION study

2024-1-1

The protocol for an observational Australian cohort study of CADASIL: The AusCADASIL study

2024-1-1

SYSTEMIC ENDOTHELIAL FUNCTION AND CEREBRAL MICROBLEEDS: A CROSS-SECTIONAL ANALYSIS WITHIN THE RHINELAND STUDY

2024-1-1

Longitudinal trajectories of cognitive decline and cerebral blood flow abnormalities in octogenarian men with normal global cognition

2024-1-1

PERIVASCULAR FIBROBLASTS ACTIVITY PRECEDES THE ONSET OF ALS NEURODEGENERATION WITH HIGH PLASMA SPP1 ASSOCIATED WITH SHORT PATIENT SURVIVAL

2024-1-1

What matters to people and families affected by cerebral small vessel disease (SVD)? A qualitative grounded theory investigation

2024-1-1

Blood pressure variability and white matter hyperintensities after ischemic stroke

2024-1-1

Low serum HDL-cholesterol is associated with increased risk of the subcortical small vessel type of dementia

2024-1-1

VENOUS COLLAGENOSIS, WHITE MATTER HYPERINTENSITY AND THE PERIVASCULAR SPACE

2024-1-1

VALIDATION OF A NOVEL CLINICAL NEUROVASCULAR COUPLING BIOMARKER

2024-1-1

A CLUSTER OF BLOOD-BASED BIOMARKERS REFLECTING COAGULATION RELATES TO THE BURDEN OF CEREBRAL SMALL VESSEL DISEASE

2024-1-1

Astaxanthin and Improvement of Dementia: A Systematic Review of Current Clinical Trials

2024-1-1

SERUM PLACENTAL GROWTH FACTOR AS A MARKER OF CEREBROVASCULAR DISEASE BURDEN IN PATIENTS WITH ALZHEIMER'S DISEASE

2024-1-1

Findings of an Internationally Collaborative Genome Wide Association Study of Vascular Cognitive Impairment

2024-1-1

AGE-ASSOCIATED CHANGES IN THE RENIN-ANGIOTENSIN SYSTEM: IMPLICATIONS FOR FUTURE CLINICAL TRIALS

2024-1-1

WITHDRAWN

2024-1-1

RENIN-ANGIOTENSIN SYSTEM GENE EXPRESSION AND DEMENTIA PATHOLOGY IN ALZHEIMER'S DISEASE, VASCULAR AND MIXED DEMENTIA

2024-1-1

The iceberg of dementia risk: empirical and conceptual arguments in favor of structural interventions for brain health

2024-1-1

Fluid biomarkers of the neurovascular unit in cerebrovascular disease and vascular cognitive disorders: A systematic review and meta-analysis

2024-1-1

Most common NOTCH3 mutations causing CADASIL or CADASIL-like cerebral small vessel disease: A systematic review

2024-1-1

Perspectives of general practitioners and memory clinic patients on ageing and cognitive decline to inform the design of a decentralised antihypertensive dementia prevention trial.

2024-1-1

Individuals with dementia and populations with dementia

2024-1-1

DOES WHITE MATTER HYPERINTENSITY LOCATION PREDICT COGNITIVE IMPAIRMENT IN AN ELDERLY POPULATION?

2024-1-1

VISUOSPATIAL DYSFUNCTION IN VASCULAR COGNITIVE IMPAIRMENT SUBTYPES- A COMPARATIVE STUDY FROM A TERTIARY CARE CENTER IN KOLKATA.

2024-1-1

THE BRAIN RENIN-ANGIOTENSIN SYSTEM IS ALTERED IN AGE AND ALZHEIMER'S DISEASE

2024-1-1

Plasma Phosphorylated-tau181 is a Predictor of Poststroke Cognitive Impairment: A Longitudinal Study

2024-1-1

Various modalities of resistance exercise promote similar acute cognitive improvements and hemodynamic increases in young, healthy adults

2024-1-1

The Promise of Molecular Science in Brain Health. What breakthroughs are anticipated in the next 20 years?

2024-1-1

Clinical value of plasma brain-derived tau and p-tau217 in acute ischemic stroke

2024-1-1

FIBRINOGEN ACTIVATES MICROGLIA AND DRIVES EXTRACELLULAR VESICLE MEDIATED PROPAGATION OF PRO-INFLAMMATORY SIGNALING

2024-1-1

PREVALANCE OF, AND RISK FACTORS FOR, VASCULAR COGNITIVE IMPAIRMENT IN CADASIL

2024-1-1

Strategic white matter hyperintensity locations and cognitive functioning in community-dwelling individuals: rationale and design

2024-1-1

National and international collaborations to advance research into vascular contributions to cognitive decline

2024-1-1

The Acceptability of post-stroke cognitive testing through the lens of the theory of acceptability, a qualitative study

2024-1-1

Is the difference real, is the difference relevant: the minimal detectable and clinically important changes in the Montreal Cognitive Assessment

2024-1-1

CADASIL Registry in East Asia (CADREA): Protocol for an international prospective cohort study

2024-1-1

High cognitive reserve mitigates the risk of dementia related to cardiometabolic diseases

2024-1-1

Exploring the link between biologically defined resilience, brain pathology, and cognitive functioning in old age and the contribution of biological sex

2024-1-1

Cerebral blood flow as intermediary between cardiovascular and cerebrovascular health: results from the Insight46 study

2024-1-1